Houston Emergency Opioid Engagement System
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT03396276
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Suboxone — DRUG8mg of buprenorphine/2mg of naloxone
- Brief counseling in the ED — BEHAVIORALPatients will receive brief counseling from ED physician prior to discharge about the options for outpatient treatment, as well as opioid dependency.Consented patients will be provided with a pamphlet from the Substance Abuse and Mental Health Services Administration called "Facts About Buprenorphine", as well as an information packet for study contact information for the opioid recovery network providers.
- Referral to outpatient treatment — BEHAVIORALA referral will be made to one of the affiliated MAT clinics.
- Follow-up coaching — BEHAVIORALA designated paramedic with the Houston Fire Department (called the navigator or care coordinator) will work with UTHealth to jointly follow-up on patients both telephonically and in-person. The Houston Fire Department paramedic will provide brief information sharing and assist with coordination in scheduling or registering with MAT clinics or recovery coaching.
Study Details
The Houston Emergency Response Opioid Engagement System (HEROES) is a community-based research program integrating assertive outreach, medication-assisted treatment, behavioral counseling, peer recovery support, and paramedic follow-up in Houston Texas. The objective is to compare differences in engagement and retention in treatment for individuals with opioid use disorder.
Key Dates
- Start date
- Apr 1, 2018
- Status verified
- Sep 2025
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 3,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Suboxone induction into MAT in the EDSuboxone induction into medication-assisted treatment (MAT) in the emergency department (ED)
Primary Outcome Measure
Patient enrollment in outpatient treatment [ Time Frame: at the time of enrollment in outpatient treatment ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | - |
Find similar trials in Houston, TX
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUDNot Yet Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- A Study of Brenipatide in Participants With Opioid Use DisorderPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- Adjunctive Effects of Psilocybin and a Formulation of BuprenorphinePHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin